Pharmacokinetics of polatuzumab vedotin in combination with R/G-CHP in patients with B-cell non-Hodgkin lymphoma

Shemesh, CS; Agarwal, P; Lu, T; Lee, C; Dere, RC; Li, XB; Li, CZ; Jin, JY; Girish, S; Miles, D; Lu, D

Shemesh, CS; Lu, D (corresponding author), Genentech Inc, Dept Clin Pharmacol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020; 85 (5): 831

Abstract

Purpose The phase Ib/II open-label study (NCT01992653) evaluated the antibody-drug conjugate polatuzumab vedotin (pola) plus rituximab/obinutuzumab, c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索